AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1086519, encodeId=fd031086519f7, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086520, encodeId=77ec1086520ff, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849359, encodeId=48c184935931, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然只是一个3区的期刊，但是要求还是挺高的，审稿人给了非常详尽的意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Fri Jan 18 16:23:47 CST 2019, time=2019-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566324, encodeId=be1856632496, content=请教下，CCM是哪个杂志啊？ 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, beContent= 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo529PGUCLT3kFycGfictTw3vIWlica1zgqvlhasgXRghhYbqzxEjhYia26icr5gbRofddZSfDkbeDxKTZaDor17ceVg/0, createdBy=6d371685032, createdName=狮子座, createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552348, encodeId=da045523482a, content=我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?JPDXQ 2017-03-10 21:13:00 发表: 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, beContent=JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc161873651, createdName=ms709465146725499, createdTime=Sun Feb 04 00:00:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549157, encodeId=453554915e55, content=投过2次，要交50美元审稿费用。但是2次都是对文章给出直接简单的拒搞，根本没有提什么有用的意见。第1次还觉得是文章内容太偏可能编辑不好提意见，结果第2篇文章仍然简单拒了。觉得审稿费算是白交了吧，还不如先尝试其他同层次的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5e21744621, createdName=MJ NEHC, createdTime=Mon Nov 13 09:43:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544565, encodeId=8ee75445657b, content=求问各位前辈大神，这个接受率大概多少？需要审稿费么？~谢谢大神~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3ce1990791, createdName=斯诺, createdTime=Tue Jul 18 22:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543960, encodeId=0c1b543960a1, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538472, encodeId=7bbd5384e2b0, content=虽然分不高，但是业内比较认可（在国内很是吃亏），投稿的难度还是比较大，对语言的要求蛮高的（感觉审稿的都是老人），但是投稿对机制要求不深, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfba1630272, createdName=jwjin, createdTime=Wed Jun 28 09:33:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533991, encodeId=81b25339916e, content=各位前辈，我做的是肺纤维化动物实验的病理研究，机制阐述不是很深入，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2021-12-27 msSSSSSD

如何回复期刊编辑的意见？

63 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1086519, encodeId=fd031086519f7, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086520, encodeId=77ec1086520ff, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849359, encodeId=48c184935931, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然只是一个3区的期刊，但是要求还是挺高的，审稿人给了非常详尽的意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Fri Jan 18 16:23:47 CST 2019, time=2019-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566324, encodeId=be1856632496, content=请教下，CCM是哪个杂志啊？ 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, beContent= 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo529PGUCLT3kFycGfictTw3vIWlica1zgqvlhasgXRghhYbqzxEjhYia26icr5gbRofddZSfDkbeDxKTZaDor17ceVg/0, createdBy=6d371685032, createdName=狮子座, createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552348, encodeId=da045523482a, content=我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?JPDXQ 2017-03-10 21:13:00 发表: 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, beContent=JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc161873651, createdName=ms709465146725499, createdTime=Sun Feb 04 00:00:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549157, encodeId=453554915e55, content=投过2次，要交50美元审稿费用。但是2次都是对文章给出直接简单的拒搞，根本没有提什么有用的意见。第1次还觉得是文章内容太偏可能编辑不好提意见，结果第2篇文章仍然简单拒了。觉得审稿费算是白交了吧，还不如先尝试其他同层次的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5e21744621, createdName=MJ NEHC, createdTime=Mon Nov 13 09:43:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544565, encodeId=8ee75445657b, content=求问各位前辈大神，这个接受率大概多少？需要审稿费么？~谢谢大神~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3ce1990791, createdName=斯诺, createdTime=Tue Jul 18 22:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543960, encodeId=0c1b543960a1, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538472, encodeId=7bbd5384e2b0, content=虽然分不高，但是业内比较认可（在国内很是吃亏），投稿的难度还是比较大，对语言的要求蛮高的（感觉审稿的都是老人），但是投稿对机制要求不深, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfba1630272, createdName=jwjin, createdTime=Wed Jun 28 09:33:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533991, encodeId=81b25339916e, content=各位前辈，我做的是肺纤维化动物实验的病理研究，机制阐述不是很深入，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2021-12-27 衣谷

回复评审的意见和期刊编辑的意见有什么不同？

50 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1086519, encodeId=fd031086519f7, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086520, encodeId=77ec1086520ff, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849359, encodeId=48c184935931, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然只是一个3区的期刊，但是要求还是挺高的，审稿人给了非常详尽的意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Fri Jan 18 16:23:47 CST 2019, time=2019-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566324, encodeId=be1856632496, content=请教下，CCM是哪个杂志啊？ 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, beContent= 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo529PGUCLT3kFycGfictTw3vIWlica1zgqvlhasgXRghhYbqzxEjhYia26icr5gbRofddZSfDkbeDxKTZaDor17ceVg/0, createdBy=6d371685032, createdName=狮子座, createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552348, encodeId=da045523482a, content=我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?JPDXQ 2017-03-10 21:13:00 发表: 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, beContent=JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc161873651, createdName=ms709465146725499, createdTime=Sun Feb 04 00:00:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549157, encodeId=453554915e55, content=投过2次，要交50美元审稿费用。但是2次都是对文章给出直接简单的拒搞，根本没有提什么有用的意见。第1次还觉得是文章内容太偏可能编辑不好提意见，结果第2篇文章仍然简单拒了。觉得审稿费算是白交了吧，还不如先尝试其他同层次的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5e21744621, createdName=MJ NEHC, createdTime=Mon Nov 13 09:43:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544565, encodeId=8ee75445657b, content=求问各位前辈大神，这个接受率大概多少？需要审稿费么？~谢谢大神~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3ce1990791, createdName=斯诺, createdTime=Tue Jul 18 22:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543960, encodeId=0c1b543960a1, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538472, encodeId=7bbd5384e2b0, content=虽然分不高，但是业内比较认可（在国内很是吃亏），投稿的难度还是比较大，对语言的要求蛮高的（感觉审稿的都是老人），但是投稿对机制要求不深, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfba1630272, createdName=jwjin, createdTime=Wed Jun 28 09:33:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533991, encodeId=81b25339916e, content=各位前辈，我做的是肺纤维化动物实验的病理研究，机制阐述不是很深入，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2019-01-18 ms9001418248751590

审稿速度:6.0 | 投稿命中率:25.0
经验分享：虽然只是一个3区的期刊，但是要求还是挺高的，审稿人给了非常详尽的意见

106 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=1086519, encodeId=fd031086519f7, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086520, encodeId=77ec1086520ff, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849359, encodeId=48c184935931, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然只是一个3区的期刊，但是要求还是挺高的，审稿人给了非常详尽的意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Fri Jan 18 16:23:47 CST 2019, time=2019-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566324, encodeId=be1856632496, content=请教下，CCM是哪个杂志啊？ 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, beContent= 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo529PGUCLT3kFycGfictTw3vIWlica1zgqvlhasgXRghhYbqzxEjhYia26icr5gbRofddZSfDkbeDxKTZaDor17ceVg/0, createdBy=6d371685032, createdName=狮子座, createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552348, encodeId=da045523482a, content=我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?JPDXQ 2017-03-10 21:13:00 发表: 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, beContent=JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc161873651, createdName=ms709465146725499, createdTime=Sun Feb 04 00:00:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549157, encodeId=453554915e55, content=投过2次，要交50美元审稿费用。但是2次都是对文章给出直接简单的拒搞，根本没有提什么有用的意见。第1次还觉得是文章内容太偏可能编辑不好提意见，结果第2篇文章仍然简单拒了。觉得审稿费算是白交了吧，还不如先尝试其他同层次的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5e21744621, createdName=MJ NEHC, createdTime=Mon Nov 13 09:43:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544565, encodeId=8ee75445657b, content=求问各位前辈大神，这个接受率大概多少？需要审稿费么？~谢谢大神~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3ce1990791, createdName=斯诺, createdTime=Tue Jul 18 22:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543960, encodeId=0c1b543960a1, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538472, encodeId=7bbd5384e2b0, content=虽然分不高，但是业内比较认可（在国内很是吃亏），投稿的难度还是比较大，对语言的要求蛮高的（感觉审稿的都是老人），但是投稿对机制要求不深, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfba1630272, createdName=jwjin, createdTime=Wed Jun 28 09:33:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533991, encodeId=81b25339916e, content=各位前辈，我做的是肺纤维化动物实验的病理研究，机制阐述不是很深入，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2019-01-30 狮子座

请教下，CCM是哪个杂志啊？ 2018-02-04 00:00:00 发表:
我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了

2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了

220 0

[GetPortalCommentsPageByObjectIdResponse(id=1086519, encodeId=fd031086519f7, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086520, encodeId=77ec1086520ff, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849359, encodeId=48c184935931, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然只是一个3区的期刊，但是要求还是挺高的，审稿人给了非常详尽的意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Fri Jan 18 16:23:47 CST 2019, time=2019-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566324, encodeId=be1856632496, content=请教下，CCM是哪个杂志啊？ 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, beContent= 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo529PGUCLT3kFycGfictTw3vIWlica1zgqvlhasgXRghhYbqzxEjhYia26icr5gbRofddZSfDkbeDxKTZaDor17ceVg/0, createdBy=6d371685032, createdName=狮子座, createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552348, encodeId=da045523482a, content=我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?JPDXQ 2017-03-10 21:13:00 发表: 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, beContent=JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc161873651, createdName=ms709465146725499, createdTime=Sun Feb 04 00:00:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549157, encodeId=453554915e55, content=投过2次，要交50美元审稿费用。但是2次都是对文章给出直接简单的拒搞，根本没有提什么有用的意见。第1次还觉得是文章内容太偏可能编辑不好提意见，结果第2篇文章仍然简单拒了。觉得审稿费算是白交了吧，还不如先尝试其他同层次的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5e21744621, createdName=MJ NEHC, createdTime=Mon Nov 13 09:43:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544565, encodeId=8ee75445657b, content=求问各位前辈大神，这个接受率大概多少？需要审稿费么？~谢谢大神~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3ce1990791, createdName=斯诺, createdTime=Tue Jul 18 22:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543960, encodeId=0c1b543960a1, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538472, encodeId=7bbd5384e2b0, content=虽然分不高，但是业内比较认可（在国内很是吃亏），投稿的难度还是比较大，对语言的要求蛮高的（感觉审稿的都是老人），但是投稿对机制要求不深, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfba1630272, createdName=jwjin, createdTime=Wed Jun 28 09:33:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533991, encodeId=81b25339916e, content=各位前辈，我做的是肺纤维化动物实验的病理研究，机制阐述不是很深入，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2018-02-04 ms709465146725499

我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了JPDXQ 2017-03-10 发表::
SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?JPDXQ 2017-03-10 21:13:00 发表:
各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?

JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?

280 0

[GetPortalCommentsPageByObjectIdResponse(id=1086519, encodeId=fd031086519f7, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086520, encodeId=77ec1086520ff, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849359, encodeId=48c184935931, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然只是一个3区的期刊，但是要求还是挺高的，审稿人给了非常详尽的意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Fri Jan 18 16:23:47 CST 2019, time=2019-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566324, encodeId=be1856632496, content=请教下，CCM是哪个杂志啊？ 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, beContent= 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo529PGUCLT3kFycGfictTw3vIWlica1zgqvlhasgXRghhYbqzxEjhYia26icr5gbRofddZSfDkbeDxKTZaDor17ceVg/0, createdBy=6d371685032, createdName=狮子座, createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552348, encodeId=da045523482a, content=我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?JPDXQ 2017-03-10 21:13:00 发表: 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, beContent=JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc161873651, createdName=ms709465146725499, createdTime=Sun Feb 04 00:00:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549157, encodeId=453554915e55, content=投过2次，要交50美元审稿费用。但是2次都是对文章给出直接简单的拒搞，根本没有提什么有用的意见。第1次还觉得是文章内容太偏可能编辑不好提意见，结果第2篇文章仍然简单拒了。觉得审稿费算是白交了吧，还不如先尝试其他同层次的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5e21744621, createdName=MJ NEHC, createdTime=Mon Nov 13 09:43:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544565, encodeId=8ee75445657b, content=求问各位前辈大神，这个接受率大概多少？需要审稿费么？~谢谢大神~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3ce1990791, createdName=斯诺, createdTime=Tue Jul 18 22:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543960, encodeId=0c1b543960a1, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538472, encodeId=7bbd5384e2b0, content=虽然分不高，但是业内比较认可（在国内很是吃亏），投稿的难度还是比较大，对语言的要求蛮高的（感觉审稿的都是老人），但是投稿对机制要求不深, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfba1630272, createdName=jwjin, createdTime=Wed Jun 28 09:33:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533991, encodeId=81b25339916e, content=各位前辈，我做的是肺纤维化动物实验的病理研究，机制阐述不是很深入，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2017-11-13 MJ NEHC

投过2次，要交50美元审稿费用。但是2次都是对文章给出直接简单的拒搞，根本没有提什么有用的意见。第1次还觉得是文章内容太偏可能编辑不好提意见，结果第2篇文章仍然简单拒了。觉得审稿费算是白交了吧，还不如先尝试其他同层次的期刊。

371 0

[GetPortalCommentsPageByObjectIdResponse(id=1086519, encodeId=fd031086519f7, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086520, encodeId=77ec1086520ff, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849359, encodeId=48c184935931, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然只是一个3区的期刊，但是要求还是挺高的，审稿人给了非常详尽的意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Fri Jan 18 16:23:47 CST 2019, time=2019-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566324, encodeId=be1856632496, content=请教下，CCM是哪个杂志啊？ 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, beContent= 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo529PGUCLT3kFycGfictTw3vIWlica1zgqvlhasgXRghhYbqzxEjhYia26icr5gbRofddZSfDkbeDxKTZaDor17ceVg/0, createdBy=6d371685032, createdName=狮子座, createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552348, encodeId=da045523482a, content=我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?JPDXQ 2017-03-10 21:13:00 发表: 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, beContent=JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc161873651, createdName=ms709465146725499, createdTime=Sun Feb 04 00:00:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549157, encodeId=453554915e55, content=投过2次，要交50美元审稿费用。但是2次都是对文章给出直接简单的拒搞，根本没有提什么有用的意见。第1次还觉得是文章内容太偏可能编辑不好提意见，结果第2篇文章仍然简单拒了。觉得审稿费算是白交了吧，还不如先尝试其他同层次的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5e21744621, createdName=MJ NEHC, createdTime=Mon Nov 13 09:43:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544565, encodeId=8ee75445657b, content=求问各位前辈大神，这个接受率大概多少？需要审稿费么？~谢谢大神~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3ce1990791, createdName=斯诺, createdTime=Tue Jul 18 22:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543960, encodeId=0c1b543960a1, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538472, encodeId=7bbd5384e2b0, content=虽然分不高，但是业内比较认可（在国内很是吃亏），投稿的难度还是比较大，对语言的要求蛮高的（感觉审稿的都是老人），但是投稿对机制要求不深, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfba1630272, createdName=jwjin, createdTime=Wed Jun 28 09:33:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533991, encodeId=81b25339916e, content=各位前辈，我做的是肺纤维化动物实验的病理研究，机制阐述不是很深入，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2017-07-18 斯诺

求问各位前辈大神，这个接受率大概多少？需要审稿费么？~谢谢大神~~

379 0

[GetPortalCommentsPageByObjectIdResponse(id=1086519, encodeId=fd031086519f7, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086520, encodeId=77ec1086520ff, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849359, encodeId=48c184935931, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然只是一个3区的期刊，但是要求还是挺高的，审稿人给了非常详尽的意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Fri Jan 18 16:23:47 CST 2019, time=2019-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566324, encodeId=be1856632496, content=请教下，CCM是哪个杂志啊？ 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, beContent= 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo529PGUCLT3kFycGfictTw3vIWlica1zgqvlhasgXRghhYbqzxEjhYia26icr5gbRofddZSfDkbeDxKTZaDor17ceVg/0, createdBy=6d371685032, createdName=狮子座, createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552348, encodeId=da045523482a, content=我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?JPDXQ 2017-03-10 21:13:00 发表: 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, beContent=JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc161873651, createdName=ms709465146725499, createdTime=Sun Feb 04 00:00:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549157, encodeId=453554915e55, content=投过2次，要交50美元审稿费用。但是2次都是对文章给出直接简单的拒搞，根本没有提什么有用的意见。第1次还觉得是文章内容太偏可能编辑不好提意见，结果第2篇文章仍然简单拒了。觉得审稿费算是白交了吧，还不如先尝试其他同层次的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5e21744621, createdName=MJ NEHC, createdTime=Mon Nov 13 09:43:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544565, encodeId=8ee75445657b, content=求问各位前辈大神，这个接受率大概多少？需要审稿费么？~谢谢大神~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3ce1990791, createdName=斯诺, createdTime=Tue Jul 18 22:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543960, encodeId=0c1b543960a1, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538472, encodeId=7bbd5384e2b0, content=虽然分不高，但是业内比较认可（在国内很是吃亏），投稿的难度还是比较大，对语言的要求蛮高的（感觉审稿的都是老人），但是投稿对机制要求不深, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfba1630272, createdName=jwjin, createdTime=Wed Jun 28 09:33:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533991, encodeId=81b25339916e, content=各位前辈，我做的是肺纤维化动物实验的病理研究，机制阐述不是很深入，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2017-07-16 wang_di98

徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了

561 0

[GetPortalCommentsPageByObjectIdResponse(id=1086519, encodeId=fd031086519f7, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086520, encodeId=77ec1086520ff, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849359, encodeId=48c184935931, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然只是一个3区的期刊，但是要求还是挺高的，审稿人给了非常详尽的意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Fri Jan 18 16:23:47 CST 2019, time=2019-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566324, encodeId=be1856632496, content=请教下，CCM是哪个杂志啊？ 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, beContent= 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo529PGUCLT3kFycGfictTw3vIWlica1zgqvlhasgXRghhYbqzxEjhYia26icr5gbRofddZSfDkbeDxKTZaDor17ceVg/0, createdBy=6d371685032, createdName=狮子座, createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552348, encodeId=da045523482a, content=我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?JPDXQ 2017-03-10 21:13:00 发表: 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, beContent=JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc161873651, createdName=ms709465146725499, createdTime=Sun Feb 04 00:00:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549157, encodeId=453554915e55, content=投过2次，要交50美元审稿费用。但是2次都是对文章给出直接简单的拒搞，根本没有提什么有用的意见。第1次还觉得是文章内容太偏可能编辑不好提意见，结果第2篇文章仍然简单拒了。觉得审稿费算是白交了吧，还不如先尝试其他同层次的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5e21744621, createdName=MJ NEHC, createdTime=Mon Nov 13 09:43:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544565, encodeId=8ee75445657b, content=求问各位前辈大神，这个接受率大概多少？需要审稿费么？~谢谢大神~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3ce1990791, createdName=斯诺, createdTime=Tue Jul 18 22:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543960, encodeId=0c1b543960a1, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538472, encodeId=7bbd5384e2b0, content=虽然分不高，但是业内比较认可（在国内很是吃亏），投稿的难度还是比较大，对语言的要求蛮高的（感觉审稿的都是老人），但是投稿对机制要求不深, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfba1630272, createdName=jwjin, createdTime=Wed Jun 28 09:33:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533991, encodeId=81b25339916e, content=各位前辈，我做的是肺纤维化动物实验的病理研究，机制阐述不是很深入，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2017-06-28 jwjin

虽然分不高，但是业内比较认可（在国内很是吃亏），投稿的难度还是比较大，对语言的要求蛮高的（感觉审稿的都是老人），但是投稿对机制要求不深

335 0

[GetPortalCommentsPageByObjectIdResponse(id=1086519, encodeId=fd031086519f7, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=63, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210511/ddebdec707734c8390a07bd0c1048717/cc11caf5d607430e9f4ca556fed68ab1.jpg, createdBy=2c4d5497888, createdName=msSSSSSD, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1086520, encodeId=77ec1086520ff, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=33c12179121, createdName=衣谷, createdTime=Mon Dec 27 14:52:47 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=849359, encodeId=48c184935931, content=审稿速度:6.0 | 投稿命中率:25.0 经验分享：虽然只是一个3区的期刊，但是要求还是挺高的，审稿人给了非常详尽的意见 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=106, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5bbd5414038, createdName=ms9001418248751590, createdTime=Fri Jan 18 16:23:47 CST 2019, time=2019-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=566324, encodeId=be1856632496, content=请教下，CCM是哪个杂志啊？ 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, beContent= 2018-02-04 00:00:00 发表: 我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了, objectType=tool_impact_factor, channel=null, level=null, likeNumber=220, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo529PGUCLT3kFycGfictTw3vIWlica1zgqvlhasgXRghhYbqzxEjhYia26icr5gbRofddZSfDkbeDxKTZaDor17ceVg/0, createdBy=6d371685032, createdName=狮子座, createdTime=Wed Jan 30 00:00:00 CST 2019, time=2019-01-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=552348, encodeId=da045523482a, content=我跟你做的一样.机制阐述也不是很深入.刚开始投CCM.chest都被拒.本来想投AJRCMB.抱了试试看的态度先投了anesthesiology.居然修回了.给了好多好多意见.补了半年多实验.后来又拿着补过的东西再转投CCM.居然也给修回了.又补了半年多实验.最后终于CCM 接收了JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?JPDXQ 2017-03-10 21:13:00 发表: 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, beContent=JPDXQ 2017-03-10 发表:: SCI(2015):4.082 SCI(2014):3.985 各位前辈.我做的是肺纤维化动物实验的病理研究.机制阐述不是很深入.投这个杂志合适吗?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=280, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bc161873651, createdName=ms709465146725499, createdTime=Sun Feb 04 00:00:00 CST 2018, time=2018-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549157, encodeId=453554915e55, content=投过2次，要交50美元审稿费用。但是2次都是对文章给出直接简单的拒搞，根本没有提什么有用的意见。第1次还觉得是文章内容太偏可能编辑不好提意见，结果第2篇文章仍然简单拒了。觉得审稿费算是白交了吧，还不如先尝试其他同层次的期刊。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=371, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d5e21744621, createdName=MJ NEHC, createdTime=Mon Nov 13 09:43:00 CST 2017, time=2017-11-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=544565, encodeId=8ee75445657b, content=求问各位前辈大神，这个接受率大概多少？需要审稿费么？~谢谢大神~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=379, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d3ce1990791, createdName=斯诺, createdTime=Tue Jul 18 22:39:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=543960, encodeId=0c1b543960a1, content=徘徊不前,不过处于这个关口上的期刊,再往上冲已不易了,4分多,也算满意了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=561, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=wang_di98, createdTime=Sun Jul 16 19:01:00 CST 2017, time=2017-07-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=538472, encodeId=7bbd5384e2b0, content=虽然分不高，但是业内比较认可（在国内很是吃亏），投稿的难度还是比较大，对语言的要求蛮高的（感觉审稿的都是老人），但是投稿对机制要求不深, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=335, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cfba1630272, createdName=jwjin, createdTime=Wed Jun 28 09:33:00 CST 2017, time=2017-06-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=533991, encodeId=81b25339916e, content=各位前辈，我做的是肺纤维化动物实验的病理研究，机制阐述不是很深入，投这个杂志合适吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=381, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=36f8106313, createdName=JPDXQ, createdTime=Fri Mar 10 21:13:00 CST 2017, time=2017-03-10, status=1, ipAttribution=)]

2017-03-10 JPDXQ

各位前辈，我做的是肺纤维化动物实验的病理研究，机制阐述不是很深入，投这个杂志合适吗？

381 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务